Endurant Capital Management’s ARS Pharmaceuticals SPRY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-84,295	Closed	-$561K	–	81
2021 Q4	$561K	Buy	+84,295	New	+$561K	0.14%	63
2021 Q3	–	Sell	-139,124	Closed	-$4.3M	–	59
2021 Q2	$4.3M	Buy	+139,124	New	+$4.3M	1.18%	33